Certified by Founder
Lodge
Encellin
start up
United States
- Mountain View
- 14/12/2023
- Unknown
- $9,900,000
Encellin is focused on advancing next generation therapies, starting with endocrine disorders.
We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases.
- Industry Biotechnology Research
- Website https://www.encellin.com/
- LinkedIn https://www.linkedin.com/company/encellin/about/
SetSale | $2,000,000 | (Mar 19, 2026)
Raven.io | $20,000,000 | (Mar 19, 2026)
Manifold Security | $8,000,000 | (Mar 19, 2026)
Beautiful.ai | $45,000,000 | (Mar 19, 2026)
xmemory | $4,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
Multiply(US) | $9,500,000 | (Mar 19, 2026)
Respan (formerly Keywords AI) | $5,000,000 | (Mar 19, 2026)
Homaio | $4,135,744 | (Mar 19, 2026)
Foresight(UK) | $25,000,000 | (Mar 19, 2026)
VerbaFlo.AI | $7,000,000 | (Mar 18, 2026)